Reference health

A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis

https://doi.org/10.1038/s41467-021-25990-w

30/30 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 30 checked references that resolve

resolves10.1016/j.ccell.2015.03.001

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

resolves10.1126/science.aaf1292

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

resolves10.1038/nrm.2017.125

Shedding light on the cell biology of extracellular vesicles

resolves10.1016/j.cell.2019.02.016

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

resolves10.1038/nature21349

Elements of cancer immunity and the cancer–immune set point

resolves10.1002/adma.201703588

1D Coordination Polymer Nanofibers for Low‐Temperature Photothermal Therapy

resolves10.1146/annurev-med-092012-112807

Immune Modulation in Cancer with Antibodies

resolves10.1016/j.cell.2013.12.010

Regulation of Ferroptotic Cancer Cell Death by GPX4

resolves10.1016/j.cell.2012.03.042

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

resolves10.1038/s41586-019-1170-y

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

resolves10.1136/jitc-2020-001369

Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity

resolves10.1016/j.bbrc.2019.01.090

The release and activity of HMGB1 in ferroptosis

resolves10.1074/jbc.M206747200

Inhibition of Tumor Necrosis Factor-induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase

resolves10.1074/jbc.M116.741884

Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation

resolves10.1038/nrc1391

Hyaluronan: from extracellular glue to pericellular cue

resolves10.1158/1535-7163.MCT-11-0755

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

resolves10.1021/nn506130t

Activatable Hyaluronic Acid Nanoparticle as a Theranostic Agent for Optical/Photoacoustic Image-Guided Photothermal Therapy

resolves10.1016/j.biomaterials.2016.10.030

Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy

resolves10.1038/ni.2647

Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity

resolves10.7150/thno.38583

Advances in Engineering Cells for Cancer Immunotherapy

resolves10.1038/s41422-020-00441-1

Ferroptosis: molecular mechanisms and health implications

resolves10.1038/ncomms14844

Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

resolves10.1038/s41586-019-1705-2

The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis

resolves10.1038/nature14344

Ferroptosis as a p53-mediated activity during tumour suppression

resolves10.1038/s41577-018-0009-3

An early history of T cell-mediated cytotoxicity

resolves10.1038/nature11824

T-helper-1-cell cytokines drive cancer into senescence

resolves10.1038/s41586-018-0392-8

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

resolves10.1158/1078-0432.CCR-17-2664

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

resolves10.1073/pnas.1203479109

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model

resolves10.1080/20013078.2020.1722433

Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation

The 1 reference without a DOI — listed, not checked

no DOI — not checkedEliaz, R. E. & Szoka, F. C. Jr Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61, 2592–2601 (2001).

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/s41467-021-25990-w"><img src="https://citestamp.com/citestamped/10.1038/s41467-021-25990-w/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/s41467-021-25990-w/badge.svg)](https://citestamp.com/citestamped/10.1038/s41467-021-25990-w)